Throughout the entire pharmaceutical process, from research to quality control, the use of either one of these liquid chromatographs (HPLC or UHPLC) may be encountered. In addition, direct analysis using the pharmacopeia-specified analytical conditions may not be possible due to the pressure tolerance of your current LC instrument. To facilitate the seamless transfer of LC analytical methods, Shimadzu developed the integrated LC system, Nexera™-i MT. This system, which contains two independent flow paths, requires no need for changing of columns and allows effortless method transfer (UHPLC ⇔ HPLC) in a single instrument.
In this article, the analysis of irbesartan and amlodipine besilate was performed using Nexera™-i MT. Our results show the reliable transfer of the listed analytical conditions for these two compounds, and also fulfilled the criteria for the system suitability test by the Japanese Pharmacopeia.
To download your copy of this application note complete the form opposite.
Registrants for this application note are covered by the Eclipse Business Media privacy policy. Information you provide will be shared with the sponsors for this content. Eclipse Business Media Ltd may contact you to offer you content based on your specific interests. You may opt-out at any time.
Eclipse Business Media Ltd, Regd in England, No. 06513189, Woodview, Bull Lane Industrial Estate, Sudbury, CO10 0FD, United Kingdom, T +44 (0)161 818 7434, info@sepscience.com
Eclipse Business Media Ltd needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy or contact privacy@labxmediagroup.com
Copyright © 2023. All rights reserved